Primary Urethral Melanoma: A Case Report and Literature Review

Author Type(s)

Student

Document Type

Article

Publication Date

April 2019

DOI

10.1016/j.urology.2018.12.027

Journal Title

Urology

Abstract

Patients with localized urethral melanoma have a high risk of recurrence and poor disease-specific survival. Multi-disciplinary approach including surgery, radiation therapy, and chemotherapy/immunotherapy is needed to maximize survival. Current research efforts include investigation of novel tyrosine kinases as well as the combination of targeted therapies with immunotherapies in this population. Combinations may provide a synergistic effect to overcome various obstacles to disease response.

Share

COinS